Compare Keel Infrastructure Corp. Common Stock (KEEL) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keel Infrastructure Corp. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Keel Infrastructure Corp. Common Stock trades at $3.08 (market cap $1.93B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.64 (market cap $2.27B). The key difference: SELLAS Life Sciences Group Inc. Common Stock is the larger of the two by market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals.
| KEEL | SLS | |
|---|---|---|
Market Cap | $1.93B | $2.27B |
Volume | 30,868,523 | 4,179,659 |
Sector | Technology | Health |
52-Week High | $6.66 | $15.46 |
52-Week Low | $1.71 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $2.25B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
